Home › Funds › Opaleye Management Inc. › MBX

Opaleye Management Inc. position in MBX

MBX BIOSCIENCES INC COM · Health Care

Opaleye Management Inc. reported holding 260,000 shares of MBX (MBX BIOSCIENCES INC COM) in its Q2 2026 13F filing — a position valued at US$14.4M, representing 1.30% of its reported portfolio and ranking #22 among its reported holdings. Opaleye Management Inc. has disclosed MBX holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)260.00K sh
Reported value held$14.35M
Portfolio Weight1.30%
First reportedQ1 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Opaleye Management Inc.'s MBX position evolved

Opaleye Management Inc. first disclosed a stake in MBX in Q1 2025 at 250,000 shares (US$1.8M). The position peaked in Q2 2026 at 260,000 shares, worth US$14.4M. Across 6 filings, Opaleye Management Inc. increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 260,000 shares valued at US$14.4M.

Quarter by quarter

QuarterSharesValueChange
Q1 2025 250.00K $1.84M New
Q2 2025 239.32K $2.73M Reduce
Q3 2025 253.00K $4.43M Add
Q4 2025 260.00K $8.20M Add
Q1 2026 260.00K $7.76M Hold
Q2 2026 260.00K $14.35M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MBX and 13F data

MBX (MBX BIOSCIENCES INC COM) is a Health Care company. 73 other funds we track also report a position in MBX — the largest reported positions include Frazier Life Sciences Management, L.P. (US$367.2M), NEA Management Company, LLC (US$199.5M), ORBIMED ADVISORS LLC (US$189.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MBX

All MBX fund holders →

FAQ

How long has Opaleye Management Inc. held MBX?

Opaleye Management Inc. has disclosed MBX holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is Opaleye Management Inc.'s current position in MBX?

As of Q2 2026, Opaleye Management Inc. holds 260.00K shares of MBX (MBX BIOSCIENCES INC COM), valued at $14.35M, representing 1.30% of its reported portfolio and ranking #22.

Has Opaleye Management Inc. been buying or selling MBX?

In the latest 13F filing (Q2 2026), Opaleye Management Inc. held unchanged its position in MBX. The position peaked in Q2 2026 at 260.00K shares.

Which other funds hold MBX?

Other major institutional holders of MBX include Frazier Life Sciences Management, L.P., NEA Management Company, LLC, ORBIMED ADVISORS LLC, among 73 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.